Class 2 recall-Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion

Hameln Pharma Ltd is recalling the batches of Clarithromycin 500 mg powder for concentrate for solution for infusion listed in the table. Following an inspection of the clarithromycin lactobionate raw material manufacturer, the certification of suitability for use in medicines was withdrawn due to non-compliance with Good Manufacturing Practice.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-clarithromycin-500-mg-powder-for-concentrate-for-solution-for-infusion-el-25-a-slash-53?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a7aee035-dcbb-4a49-acb7-05dc0d52d0d7&utm_content=immediately

MHRA drug alert date: 11/12/25

Further Information

For all medical information enquiries and information on this product, please email drug.safety@hameln-pharma.co.uk or telephone +44 (0)1452 621 661.

For stock control enquiries please email customer.services@hameln-pharma.co.uk , or telephone +44 (0)1452 621 661.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.